| abstract |
In the present invention, an oral dosage form is provided which comprises a pharmaceutically acceptable excipient which is, as active ingredient, bendamustine or a pharmaceutically acceptable ester, salt or solvate thereof, and a pharmaceutically acceptable non-ionic hydrophilic surfactant. A pharmaceutical composition is provided. |